A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
Completed · Phase 2
Conditions studied: Lymphoma, Non-Hodgkin's
In brief
Subjects who qualify will receive oral lenalidomide daily on days 1-21 of every 28 day cycle. Treatment will continue until disease progression, or unacceptable adverse events develop
Key facts
- Study ID
- NCT00413036
- Run by
- Celgene
- People needed
- 217
- Starts
- 2006-06-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2017-03-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Scottsdale — Scottsdale, Arizona, United States
- Lalita Pandit, MD, Inc — Fountain Valley, California, United States
- Access Clinical Research — Rancho Mirage, California, United States
- Kaiser Permanente Medical Group — San Diego, California, United States
- Pasco Hernando Oncology Associates — Brooksville, Florida, United States
- Sylvester Cancer Center/ Univeristy of Miami — Miami, Florida, United States
- Hematology Oncology Associates of Central Brevard — Rockledge, Florida, United States
- Palm Beach Cancer Institute — West Palm Beach, Florida, United States
- Cancer Care Center, Inc. — New Albany, Indiana, United States
- Ochsner Clinic Foundation — Baton Rouge, Louisiana, United States
- Michigan Hematology and Oncology Institute — Southgate, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- University of Nebraska — Omaha, Nebraska, United States
- Center for Cancer and Hematologic Disease — Cherry Hill, New Jersey, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Our Lady of Mercy Cancer Center — The Bronx, New York, United States
- HIllman Cancer Center -UPMC — Pittsburgh, Pennsylvania, United States
- Palmetto Hematology Oncology — Spartanburg, South Carolina, United States
- Family Cancer Center — Collierville, Tennessee, United States
- London Health Science Center — London, Ontario, Canada
- Saskatoon Cancer Center — Saskatoon, Saskatchewan, Canada
- Toronto Sunnybrook Regional Cancer Centre — Toronto, Canada
- Service d'Hématologie Clinique — Créteil, France
- Clinical Haematology Department — Dijon, France
- Northwest Alabama Cancer Center, PC — Muscle Shoals, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.